Importer of Controlled Substances Application: Fisher Clinical Services, Inc., 30982-30983 [2021-12212]
Download as PDF
<![CDATA[
30982
Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Notices
Management Ltd, London, UNITED
KINGDOM; Ameren Services, St. Louis,
MO; Anterix, Woodland Park, NJ; ATT
Business, Dallas, TX; BEC Technologies,
Richardson, TX; Blinq Network,
Markham, CANADA; Bridgewater
Group Consulting, Irvine, CA; Burns
and McDonnell, Kansas City, MO; Cisco,
San Jose, CA; Council Rock, Rochester,
NY; CrescoNet, San Francisco, CA;
Encore Networks, Chantilly, VA;
Ericsson, Plano, TX; Evergy, Kansas
City, MO; GE Industrial
Communications, Rochester, NY;
Hitachi-ABB, Raleigh, NC; JEA,
Jacksonville, FL; K and A Engineering,
White Plains, NY; L3 Harris, Rochester,
NY; Mimomax Wireless, Christchurch,
NEW ZEALAND; Motorola Solutions,
Chicago, IL; Multi Tech Systems,
Mounds View, MN; Nokia, Coppell, TX;
NovaTech, Lenexa, KS; National Rural
Telecommunications Cooperative,
Herndon, VA; NY Power Authority
(NYPA), White Plains, NY; Palmetto
Technology Associates, Kiawah Island,
SC; Puloli, Inc., San Francisco, CA;
Southern California Edison, Rosemead,
CA; SouthernLinc, Atlanta, GA; Telit
Wireless Solutions, Durham, NC; World
Wide Technology, Maryland Heights,
MO; and Xcel Energy, Minneapolis, MN.
UBBA was formed as a Delaware nonstock member corporation. The general
area of UBBA’s planned activity is to
empower utilities and ecosystem
partners to champion the development
of utility broad-band networks as a key
enabler of the utility of the future, and
to undertake such other activities as
may from time to time be appropriate to
further the purposes and achieve the
goals set forth above.
Membership in UBBA remains open
and UBBA intends to file additional
written notifications disclosing all
changes in membership.
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2021–12180 Filed 6–9–21; 8:45 am]
BILLING CODE 4410–11–P
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 12, 2021. Such persons
may also file a written request for a
hearing on the application on or before
July 12, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on May 6, 2021, Cambrex
Charles City, 1205 11th Street, Charles
City, Iowa 50616–3466, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
4-Anilino-N-Phenethyl4-Piperidine (ANPP).
Phenylacetone ..............
Coca leaves ..................
Opium, raw ...................
Poppy Straw Concentrate.
Drug Enforcement Administration
[Docket No. DEA–847]
Importer of Controlled Substances
Application: Cambrex Charles City
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
William T. McDermott,
Assistant Administrator.
Cambrex Charles City has
applied to be registered as an importer
BILLING CODE 4410–09–P
AGENCY:
SUMMARY:
VerDate Sep<11>2014
17:15 Jun 09, 2021
Jkt 253001
Schedule
8333
II
8501
9040
9600
9670
II
II
II
II
The company plans to import the
listed controlled substances for internal
use and to bulk manufacture other
controlled substances in Active
Pharmaceutical Ingredient (API) form
for distribution to its customers. No
other activity for these drug codes is
authorized for this registration.
DEPARTMENT OF JUSTICE
khammond on DSKJM1Z7X2PROD with NOTICES
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
[FR Doc. 2021–12215 Filed 6–9–21; 8:45 am]
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–844]
Importer of Controlled Substances
Application: Fisher Clinical Services,
Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Fisher Clinical Services, Inc.
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 12, 2021. Such persons
may also file a written request for a
hearing on the application on or before
July 12, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on May 17, 2021, Fisher
Clinical Services, Inc. 7554 Schantz
Road, Allentown, Pennsylvania 18106–
9032 applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUMMARY:
Controlled substance
Marihuana Extract ........
Drug
code
7350
Schedule
I
The company plans to import the listed
controlled substances for clinical trails
only. No other activity for these drug
codes is authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
E:\FR\FM\10JNN1.SGM
10JNN1
30983
Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Notices
import of the Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–12212 Filed 6–9–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–845]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Maridose,
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 9, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket
No—DEA–845 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
khammond on DSKJM1Z7X2PROD with NOTICES
DATES:
VerDate Sep<11>2014
17:15 Jun 09, 2021
Jkt 253001
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). In addition
to seeking to produce marihuana
extract, this applicant is separately
seeking to cultivate marihuana. See
Notice of Application, Bulk
Manufacturers of Marihuana, 84 FR
44920, 44922 (Aug. 27, 2019). DEA thus
will conduct this evaluation in the
manner described in the rule published
at 85 FR 82333 on December 18, 2020,
and reflected in DEA regulations at 21
CFR part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on May 6, 2021, Maridose, LLC., 74
Orion Street, Brunswick, Maine 04011,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substances:
Drug
code
Controlled substance
I
Marihuana Extract ........
7350
Schedule
II
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–12213 Filed 6–9–21; 8:45 am]
ACTION:
Notice of application.
National Center for Natural
Products Research has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 12, 2021. Such persons
may also file a written request for a
hearing on the application on or before
July 12, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on April 14, 2021,
National Center for Natural Products
Research, 806 Hathorn Road, 135 Coy
Waller Lab, University, Mississippi
38677–1848, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Marihuana Extract ..........
Marihuana .......................
Tetrahydrocannabinols ...
Drug
code
Schedule
7350
7360
7370
I
I
I
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–843]
Importer of Controlled Substances
Application: National Center for
Natural Products Research
Drug Enforcement
Administration, Justice.
AGENCY:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
The company plans to acquire new
genetic materials with improved
Cannabinoids for research and
manufacturing purposes. No other
activity for these drug codes is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of FDA-approved or non-
E:\FR\FM\10JNN1.SGM
10JNN1
]]>Agencies
[Federal Register Volume 86, Number 110 (Thursday, June 10, 2021)]
[Notices]
[Pages 30982-30983]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12212]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-844]
Importer of Controlled Substances Application: Fisher Clinical
Services, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Fisher Clinical Services, Inc. has applied to be registered as
an importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before July 12, 2021.
Such persons may also file a written request for a hearing on the
application on or before July 12, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on May 17, 2021, Fisher Clinical Services, Inc. 7554
Schantz Road, Allentown, Pennsylvania 18106-9032 applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract...................... 7350 I
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
clinical trails only. No other activity for these drug codes is
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the
[[Page 30983]]
import of the Food and Drug Administration-approved or non-approved
finished dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-12212 Filed 6-9-21; 8:45 am]
BILLING CODE 4410-09-P
